Skip to content
1st Counsel – Lifestyle
Author:
Sitryx Therapeutics
Sitryx to Participate in Upcoming Investor Conferences
May 18, 2026
Sitryx nominates novel, oral GLS1 inhibitor for clinical development in moderate to severe asthma
April 2, 2026
Sitryx to participate in upcoming April investor conferences
March 26, 2026